# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Hatshepsut (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC006-SYN
- Date: 2026-06-30
- Fictional facility: St. Posthumous Health Center
- Fictional author: Amunet Okafor-Harrington, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Ms. Hatshepsut is a 48-year-old woman with type 2 diabetes found eleven weeks ago, periodontitis, and knee osteoarthritis, who comes for the preventive visit booked at intake. The urinary symptoms settled within two days of nitrofurantoin, and she finished the five days; the culture grew Escherichia coli sensitive to it. She is ready to step up semaglutide to 0.5 mg today. Her extraction site has healed and scaling and root planing is booked with the dental team. Her periods have been irregular for a year, with occasional night sweats that do not trouble her. She has never had a mammogram or colorectal screening, and her last cervical screening was more than five years ago. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 48 |
| Cystitis | Resolved; culture-sensitive Escherichia coli |
| Diabetes | Metformin and semaglutide 0.25 mg; stepping up to 0.5 mg today |
| Mood | PHQ-2 0 |

## Health risk assessment

Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Okafor-Harrington. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, better than in the spring |
| Psychosocial | Demanding work she enjoys; trusted advisers; feels safe at home |
| Substance use | AUDIT-C 1; no drug use |
| Tobacco | Never |
| Physical activity | Walks about 100 minutes a week; knee exercises three times a week |
| Nutrition | Smaller evening meals since starting semaglutide; fewer dates and less sweet tea |
| Sleep | Seven hours; occasional night sweats |
| Safety | Wears a seat belt; no firearm at home; screen for intimate partner violence negative |
| Sexual and reproductive health | Not sexually active at present; no pregnancy plans; periods irregular for a year |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; weight down 3 kg since intake, as intended |
| Eyes | Negative | No change in vision; retinal photographs normal last month |
| Ears, nose, mouth, and throat | Negative | Extraction site healed; no gum pain |
| Cardiovascular | Negative | No chest pain or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Positive | Mild fullness after large meals; no vomiting, change in bowel habit or blood in the stool |
| Genitourinary | Positive | Irregular periods for a year; no urinary symptoms now |
| Musculoskeletal | Positive | Knee pain on stairs, easier with exercises and the gel; no other bone or joint pain |
| Integumentary | Negative | No rash or changing moles |
| Endocrine | Positive | Occasional night sweats; thirst and night urination gone |
| Breast | Negative | No lump, pain or nipple discharge |
| Psychiatric | Negative | Mood good; PHQ-2 0 |

12 systems reviewed. **S**

## Current medications

- Metformin extended-release 500 mg tablet, one tablet with the evening meal for one week, then two tablets (1000 mg) with the evening meal **S**
- Diclofenac sodium 1% gel, 4 g to each painful knee up to four times a day as needed **S**
- Semaglutide 0.5 mg subcutaneous injection once weekly (maintenance dose for now) **S**
- Atorvastatin 20 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/78 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 90 kg; BMI 35.2 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 1. All results are synthetic.

## Immunizations given today

- Pneumococcal conjugate vaccine, 20-valent (PCV20), single dose for an adult with diabetes **S**
- Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) **S**
- Hepatitis B vaccine (HepB-CpG), dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 90.0 kg, BMI 35.2; blood pressure 120/78 |
| Mouth | Extraction socket healed; gums red with calculus, as before periodontal therapy |
| Neck | Thyroid normal; no lymph nodes |
| Breasts | No masses, skin change or axillary nodes |
| Cardiovascular | Regular rhythm; no murmur |
| Abdomen | Soft and non-tender |
| Pelvic | Speculum examination with her consent and a chaperone; normal cervix; HPV sample taken |
| Musculoskeletal | Crepitus in both knees without effusion; no bone tenderness |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. PCV20, Tdap and the first hepatitis B dose given; HIV, hepatitis B and hepatitis C screening sent; primary HPV test taken; mammography and a fecal immunochemical test ordered. **S**
   - Second hepatitis B dose at a nurse visit in four weeks.
   - Influenza and COVID-19 vaccines in the autumn.
   - Zoster vaccine from 50.
   - Next preventive visit in one year.
2. **Bone health, and no search for bone cancer**. No bone pain beyond her knees, no bone tenderness, normal calcium and alkaline phosphatase, and the only weight loss is intended, so there is no reason to look for bone cancer or other bone disease. Bone density testing is not yet indicated at 48 without a risk factor. Weight loss on semaglutide can reduce bone and muscle, which strengthening exercise and enough protein help to protect. **S**
   - Weight-bearing and strengthening exercise.
   - Calcium from food and adequate vitamin D.
   - Bone density testing at 65, or sooner if a risk factor appears.
3. **Acute cystitis, resolved** (N30.00). Resolved on nitrofurantoin; culture-sensitive. **S**
   - No further action.
4. **Type 2 diabetes** (E11.65). Thirst and night urination gone; mild fullness on semaglutide 0.25 mg. **S**
   - Semaglutide 0.5 mg weekly from today.
   - A1c and lipids at the fourteen-week review.

## Medication changes

- Stopped: Semaglutide 0.25 mg subcutaneous injection once weekly (starting dose, planned for four weeks) **S**
- Started: Semaglutide 0.5 mg subcutaneous injection once weekly (maintenance dose for now) **S**

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 120/78 mmHg |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Tobacco use | Completed today | Never smoked |
| Intimate partner violence screening | Completed today | Negative |
| Breast cancer screening | Ordered | Screening mammography every two years from 40; never screened |
| Cervical cancer screening | Completed today | Primary HPV test today; last screening more than five years ago |
| Colorectal cancer screening | Ordered | Fecal immunochemical test kit given; colonoscopy if positive or if she prefers it |
| Diabetes complications | Up to date | Retinal photographs and a comprehensive foot examination last month; urine albumin normal at intake |
| Lipid screening and statin | Up to date | On atorvastatin since last month; lipids at the next review |
| Bone density testing | Not indicated | Age 48 without a risk factor; at 65 or sooner if one appears |
| HIV screening | Completed today | Once for adults 15 to 65; sent today |
| Hepatitis C screening | Completed today | Once for adults 18 to 79; sent today |
| Hepatitis B screening | Completed today | Once for all adults; sent today before the first vaccine dose |
| Pneumococcal vaccine | Completed today | PCV20, one dose, for diabetes |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap; no booster recorded within ten years |
| Hepatitis B vaccine | Completed today | Dose 1 of 2 today, for an adult with diabetes under 60 |
| Influenza vaccine | Due | In the autumn |
| COVID-19 vaccine | Due | In the autumn |
| Zoster vaccine | Not indicated | Begins at 50 |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment for any illness from which she could return to her work and her household, and would not want her life prolonged if she could no longer know the people around her. She named a health care agent, recorded in the confidential part of the chart and not named here. To be revisited yearly. **S**

## Guideline basis

- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Breast Cancer: Screening (2024), U.S. Preventive Services Task Force
- Cervical Cancer: Screening (2018), U.S. Preventive Services Task Force
- Colorectal Cancer: Screening (2021), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Fourteen-week review with A1c, lipids and ALT and the screening results; second hepatitis B dose at a nurse visit four weeks from today. Results of HIV and hepatitis tests by phone. Next preventive visit in one year. **S**
- Next scheduled visit 2026-07-21: fourteen-week review: A1c, lipids, weight, periodontal therapy, knees, and screening results. **S**
